Phase I/II study of 3-week cycle cisplatin-gemcitabine in advanced non-small cell lung cancer.
Kusaba H, Tamura T, Shimoyama T, Hotta K, Inoue A, Nokihara H, Ueda Y, Akiyama Y, Yamamoto N, Sekine I, Kunitoh H, Ohe Y, Kodama T, Saijo N.
Kusaba H, et al. Among authors: yamamoto n.
Jpn J Clin Oncol. 2002 Feb;32(2):43-7. doi: 10.1093/jjco/hyf013.
Jpn J Clin Oncol. 2002.
PMID: 11948227
Clinical Trial.